Zura Bio
ZURA
44 hedge funds and large institutions have $71M invested in Zura Bio in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 3 reducing their positions, and 7 closing their positions.
700% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 3
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
7% more funds holding
Funds holding: 41 → 44 (+3)
2.51% more ownership
Funds ownership: 32.44% → 34.95% (+2.5%)
24% less capital invested
Capital invested by funds: $93.3M → $71M (-$22.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.65M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.56M |
| 3 |
AC
Armistice Capital
New York
|
+$1.22M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.12M |
| 5 |
Morgan Stanley
New York
|
+$499K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.8M |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.58M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.1M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$139K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$98.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Russell Investments Group
London,
United Kingdom
| – | -$231 | -35 | Closed |
|
ZURA Hedge Fund Activity: Q4 2023 in Review
44 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q4 2023, worth a combined $71M — down 24% from $93.3M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ZURA positions and 7 closed out — a net gain of 3 holders — while 24 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $2.65M. The largest seller was Logos Global Management, exiting entirely with an estimated $2.8M sold.
- 44 institutional investors held Zura Bio (ZURA) as of Q4 2023, up from 41 in Q3 2023.
- Funds reported $71M of Zura Bio stock for Q4 2023, down 24% quarter-over-quarter.
- 10 funds opened new Zura Bio positions in Q4 2023 and 7 closed out, a net change of +3 holders.
- The largest Zura Bio buyer in Q4 2023 was BlackRock, an estimated $2.65M added.
- The largest Zura Bio seller in Q4 2023 was Logos Global Management, an estimated $2.8M sold.
Based on aggregated 13F filings for Q4 2023.